Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women
Condition(s):HIV InfectionLast Updated:May 23, 2017Completed
Hide Studies Not Open or Pending
Condition(s):HIV InfectionLast Updated:May 23, 2017Completed
Condition(s):HIV; Hepatitis C, ChronicLast Updated:May 2, 2019Completed
Condition(s):HIV/AIDS; HypertensionLast Updated:May 22, 2023Recruiting
Condition(s):Edematous; Synovitis; Foreign Body Reaction; OsteolysisLast Updated:January 31, 2018Completed
Condition(s):HIV/AIDSLast Updated:September 13, 2021Completed
Condition(s):16P11.2 Deletion Syndrome; 16p11.2 Duplications; 1Q21.1 Deletion; 1Q21.1 Microduplication Syndrome (Disorder); ACTL6B; ADNP; AHDC1; ANK2; ANKRD11; ARID1B; ASH1L; BCL11A; CHAMP1; CHD2; CHD8; CSNK2A1; CTBP1; CTNNB1 Gene Mutation; CUL3; DDX3X; DNMT3A; DSCAM; DYRK1A; FOXP1; GRIN2A; GRIN2B; HIVEP2-Related Intellectual Disability; HNRNPH2; KATNAL2; KDM5B; KDM6B; KMT2C Gene Mutation; KMT2E; KMT5B; MBD5; MED13L; PACS1; PPP2R5D-Related Intellectual Disability; PTCHD1; REST; SCN2A Encephalopathy; SETBP1 Gene Mutation; SETD5; SMARCA4 Gene Mutation; SMARCC2; STXBP1 Encephalopathy With Epilepsy; SYNGAP1-Related Intellectual Disability; TBR1; ARHGEF9; HNRNPU; PPP3CA; PPP2R1A; SLC6A1; 2p16.3 Deletions; 5q35 Deletions; 5q35 Duplications; 7q11.23 Duplications; 15Q13.3 Deletion Syndrome; 16p11.2 Triplications; 16P12.2 Microdeletion; 16P13.11 Microdeletion Syndrome (Disorder); 17Q12 Microdeletion Syndrome (Disorder); 17Q12 Duplication Syndrome; 17Q21.31 Deletion Syndrome; 17q21.3 Duplications; ACTB; ADSL; AFF2; ALDH5A1; ANK3; ARX; ATRX Gene Mutation; AUTS2 Syndrome; BCKDK; BRSK2; CACNA1C; CAPRIN1; CASK; CASZ1; CHD3; CIC; CNOT3; CREBBP Gene Mutation; CSDE1; CTCF; DEAF1; DHCR7; DLG4; EBF3; EHMT1; EP300 Gene Mutation; GIGYF1; GRIN1; GRIN2D; IQSEC2-Related Syndromic Intellectual Disability; IRF2BPL; KANSL1; KCNB1; KDM3B; NEXMIF; KMT2A; MBOAT7; MEIS2; MYT1L; NAA15; NBEA; NCKAP1; NIPBL; NLGN2; NLGN3; NLGN4X; NR4A2; NRXN1; NRXN2; NSD1 Gene Mutation; PHF21A; PHF3; PHIP; POMGNT1; PSMD12; RELN; RERE; RFX3; RIMS1; RORB; SCN1A; SETD2 Gene Mutation; SHANK2; SIN3A; SLC9A6; SON; SOX5; SPAST; SRCAP; TAOK1; TANC2; TCF20; TLK2; TRIO; TRIP12; UPF3B; USP9X; VPS13B; WAC; WDFY3; ZBTB20; ZNF292; ZNF462; 2Q37 Deletion Syndrome; 9q34 Duplications; 15q15 Deletions; 15Q24 Deletion; NR3C2; SYNCRIP; 2q34 Duplication; 2q37.3 Deletion; 6q16 Deletion; 15q11.2 BP1-BP2 Deletion; 16p13.3 Deletion; 17Q11.2 Microduplication Syndrome (Disorder); 17p13.3; Xq28 Duplication; CLCN4; CSNK2B; DYNC1H1; EIF3F; GNB1; MED13; MEF2C; RALGAPB; SCN1B; YY1; Xp11.22 Duplication; PACS2; MAOA; MAOB; HNRNPC; HNRNPD; HNRNPK; HNRNPR; HNRNPUL2; 5P Deletion Syndrome; TCF7L2 Gene Mutation; HECW2Last Updated:January 16, 2024Recruiting
Condition(s):Hepatitis CLast Updated:December 1, 2023Not yet recruiting
Condition(s):HIV/AIDSLast Updated:June 10, 2021Completed
Condition(s):Coronary Artery Bypass Graft SurgeryLast Updated:July 7, 2021Completed
Condition(s):Tuberculosis; Human Immunodeficiency VirusLast Updated:June 25, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.